Grand Forks Company Helps Treat A Deadly Dog Disease - Valley News Live - KVLY/KXJB - Fargo/Grand Forks

Grand Forks Company Helps Treat A Deadly Dog Disease

Posted: Updated:
A Grand Forks research company recently found a potential treatment by using antibodies of an unlikely animal. A highly contagious viral disease - known as the Canine Parvovirus can be life-threatening to dogs. Valley News Team's "Ashley Bishop" shows us how "Avianax" hopes to eventually cure more than just dogs.
Parvovirus causes dogs to be dehydrated vomit and have diarrhea. There is a vaccine that can prevent the virus but still leaves dogs susceptible between vaccinations.
"There is a window about 3-6 months if the vaccine hasn't take effect," says University of North Dakota research assistant professor Dr. Tom Henderson.
Up until now, supportive care has been the only option for dogs and puppies.

"Drips, antibiotics and anti vomit drugs usually takes 5-7 days and the cost depending on where you go around the country can be $1,500 to $3,000," says Dr. Henderson.
If a dog or puppy contracts Caine Parvovirus the survival rate for supportive care has been about 50% but now a new treatment developed in Grand Forks gives a survival rate of 90%.
"Gives the animal the shot once it is determined they have Parvovirus and in 24 hours they get another shot, and we have had evidence with in 12 hours of the first shot the animals can drink again," says Dr. Henderson.
The new treatment is called "Parvo-One" and will be one third of the cost of supportive treatment. Avianax discovered that using the antibodies in goose egg yoke can treat 12 other viruses like rabies and avian flu. Avianax hopes that one day goose antibodies can help treat disease in humans.
"If you can cure puppies I really think you could treat childhood disease and disease in the elderly," says Avianax Chief Operating Officer Richard Glynn.
Currently the United States Department of Agriculture granted an experimental license and the treatment has been tested on a variety of breeds of 50 dogs in seven states ( North Dakota, Minnesota, Iowa, Texas, Missouri, North Carolina, and Arizona). The testing trail will continue through fall.
"It has been an absolute god send it gives us hope and we had a liter of puppies that went through the treatment and before we were luck if any of those puppies would survive," says Circle of Friends Humane Society Executive Director Arlette Moen.
The Parvo-One treatment will hit the market early next year and Avianax officials say the U.S. Army has interest in using a similar anti-body technology for treating the hanta-virus and trials for that study are set to begin in a few years. 

Avianax uses about 1-2 thousand geese eggs a year for reseach and the geese are from a South Dakota-based Schiltz Goose Farm.
Powered by WorldNow
Powered by 

WorldNowAll content © Copyright 2000 - 2014 WorldNow and Valley News Live. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.